Publications by authors named "Dominique Francon"

Claim this Profile
T
Type 2/Th2-driven inflammation impairs olfactory sensory neurogenesis in mouse chronic rhinosinusitis model.
Angela Rouyar, Marion Classe, Raphael Gorski, Marie-Dominique Bock, Joelle Le-Guern

Allergy· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo triarylmethyl radical stabilization through encapsulation in Pluronic F-127 hydrogel.
Kahina Abbas, Audrey Boutier-Pischon, Florian Auger, Dominique Françon, Antonio Almario

J Magn Reson· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of T-type calcium channels prevents tonic-clonic seizures in a maximal electroshock seizure model.
Sophie Sakkaki, Giuseppe Gangarossa, Benoit Lerat, Dominique Françon, Luc Forichon

Neuropharmacology· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents.
Guy Griebel, Philippe Pichat, Sandra Beeské, Thibaud Leroy, Nicolas Redon

Sci Rep· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a potent, selective, and orally bioavailable histamine H3 receptor antagonist SAR110068 for the treatment of sleep-wake disorders.
Zhongli Gao, William J Hurst, Werngard Czechtizky, Dominique Francon, Guy Griebel

Bioorg Med Chem Lett· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Further evidence for the sleep-promoting effects of 5-HT₂A receptor antagonists and demonstration of synergistic effects with the hypnotic, zolpidem in rats.
Guy Griebel, Sandra Beeské, Agnès Jacquet, Christian Laufrais, Richard Alonso

Neuropharmacology· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stimulation of the beta3-Adrenoceptor as a novel treatment strategy for anxiety and depressive disorders.
Jeanne Stemmelin, Caroline Cohen, Jean-Paul Terranova, Matilde Lopez-Grancha, Philippe Pichat

Neuropsychopharmacology· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile.
Bruno Biton, Olivier E Bergis, Frédéric Galli, Alain Nedelec, Alistair W Lochead

Neuropsychopharmacology· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurochemical, electrophysiological and pharmacological profiles of the selective inhibitor of the glycine transporter-1 SSR504734, a potential new type of antipsychotic.
Ronan Depoortère, Gihad Dargazanli, Genevieve Estenne-Bouhtou, Annick Coste, Christophe Lanneau

Neuropsychopharmacology· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SSR181507, a dopamine D(2) receptor antagonist and 5-HT(1A) receptor agonist. I: Neurochemical and electrophysiological profile.
Yves Claustre, Danielle De Peretti, Philippe Brun, Christiane Gueudet, Nathalie Allouard

Neuropsychopharmacology· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SSR181507, a dopamine D2 receptor antagonist and 5-HT1A receptor agonist. II: Behavioral profile predictive of an atypical antipsychotic activity.
Ronan Depoortere, Denis Boulay, Ghislaine Perrault, Olivier Bergis, Michel Decobert

Neuropsychopharmacology· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms.
Guy Griebel, Ghislaine Perrault, Jacques Simiand, Caroline Cohen, Patrick Granger

CNS Drug Rev· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis